SPG20 ELISA Kit
-
- Target Alle SPG20 Produkte
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- Reaktivität
- Human
- Nachweismethode
- Colorimetric
- Methodentyp
- Sandwich ELISA
- Detektionsbereich
- 0.156 ng/mL - 10 ng/mL
- Untere Nachweisgrenze
- 0.156 ng/mL
- Applikation
- ELISA
- Verwendungszweck
- Human Spartin/SPG20 ELISA Kit is an ELISA Kit against Spartin/SPG20.
- Proben
- Plasma, Serum, Tissue Homogenate
- Analytische Methode
- Quantitative
- Sensitivität
- < 0.094 ng/mL
-
- Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plattentyp
- Pre-coated
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Haltbarkeit
- 6 months
-
- Target Alle SPG20 Produkte
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- Andere Bezeichnung
- Spartin/SPG20 (SPG20 Produkte)
- UniProt
- Q8N0X7
- Pathways
- Regulation of Cell Size, SARS-CoV-2 Protein Interaktom
-